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Nutrigenomics, a term derived from ‘nutrition’ and ‘genomics’, analyses the interactions of nutrients/dietary 
bioactive components with the genome. The 
purpose of nutrigenomics is to comprehend the 
body’s response to various diets and food through 
various high-throughput ‘omics’ techniques— 
including genomics, transcriptomics, proteomics 
and metabolomics.1 Genomics makes use of 
techniques such as recombinant deoxyribonucleic 
acid (DNA) and DNA sequencing methods to 
sequence, assemble and analyse the structure and 
function of genomes. Transcriptomics, also known 
as ‘gene expression profiling’ is the study of the 
transcriptome encoded by the genome in a given 
cell population using DNA microarray technology.2 
Proteomics is the study of the structure and function 
of proteins and is a vital component of functional 
genomics. Apart from being used in the analysis of 
gene expression in tissues, proteomics can also be 
used for the identification of new protein biomarkers 
that can be detected in plasma.3 Metabolomics is 
an emerging field of ‘omics’ research that studies 
metabolite levels in the metabolome (a set of small-
molecule metabolites) and their changes over time 
in response to stimuli. Metabolic abnormalities 
could be detected in individuals by the quantitative 
non-invasive analysis of human body fluids (such 
as urine, blood and saliva) to detect physiological 
alterations in response to the toxic effects of 
chemicals, visible in the form of lesions in the 
liver or kidneys.4 Transcriptomics has, however, 
helped in understanding the complex interactions 
between genetic and environmental factors in order 
to design nutritional interventions.5 The ‘omics’ 
applied to nutrition will ultimately lead to the 
discovery of biomarkers for early diagnosis as well as 
to the design of personalised diets that encompass 
bioactive food components of great health benefit.2 
With the success of the Human Genome Project 
and advances in technologies, a significant amount 
of information has been amassed related to human 
genes and their mechanisms. In turn, nutrigenomics 
is a new and evolving field which forms a junction 
between health, diet and genomics to analyse 
patterns of gene expression, protein expression 
and metabolite production triggered by nutrients.6 
It examines the characteristic behaviour of cells 
towards a particular nutrient and its influence on 
homeostasis. Nutrigenomics is also involved in the 
discovery of certain genes and markers during the 
initial-stages of diet-related diseases.
Nutrigenomics increases our knowledge 
about the mechanisms by which nutrition affects 
the metabolic pathways underlying homeostatic 
control. Subsequently, this can be used to determine 
naturally occurring chemical agents in food that 
could prevent the onset of diseases such as obesity, 
type-2 diabetes and cancer. The nutrients present 
in the diet are received as signals by the sensory 
system of the various cells in the body which are 
interpreted by the cells to gene expression, protein 
expression and metabolite production. Hence, 
different diet patterns elicit a variety of gene and 
protein expression and metabolite production. 
Such diet-induced patterns and their effects are 
described by nutrigenomics as “signature dietary 
patterns”. Micronutrients and macronutrients are 
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potent dietary signals that influence the metabolic 
programming of cells that play a crucial role in the 
control of homeostasis.
Nutrigenomics, which studies the interactions 
between different types of food and the genome, 
can aid in selecting foodstuffs that are vital to 
health. One of the emerging fields of research to 
use nutrigenomics is complementary alternative 
medicine (CAM). CAM is defined as a method 
of treatment that is used together with 
(complementary) or instead of (alternative) 
traditional medicine and includes meditation, 
spiritual healing, energy therapy (magnet 
therapy and light therapy), massage therapy, 
acupuncture, herbal preparations (Ayurveda), 
dietary supplements, yoga, acupressure, movement 
therapies, naturopathy and homeopathy.7–8 
CAM research has identified a number of active 
compounds from various herbal and dietary 
products and evaluated their anti-disease (e.g. 
anti-cancer) properties; these include polyphenols 
from green tea, resveratrol from grape seed/
skin, anthocyanin and pigments from numerous 
flowers, algae, fruits and vegetables. The common 
property of these compounds is their anti-oxidant/
free radical scavenging ability. Our previous study 
demonstrated that some of these compounds 
induce high free-radical formation, prevent cell 
growth and cause apoptosis selectively in cancer 
cells, but not in normal cells.9 A number of CAM 
studies have focused on the effects of individual 
compounds derived from herbs/plants used at 
‘bioavailable’ concentrations. However, only a few 
studies, including our own work, have explored 
the effects (synergistic, additive or antagonistic) of 
the combination of these compounds in diseases.9 
Interestingly, each of these individual compounds, 
when used in combination, have been found to 
target multiple signalling pathways in the cell.9 Oral 
administration of CAM natural medications has 
shown to have the great advantage of low toxicity 
and positive effects on various diseases.10—11 
In Oman, with high rates of consanguinity, 
the risk of developing genetic disorders, including 
inborn errors of metabolism is widespread.12 The 
rapid advances in nutrigenomic technology will 
ultimately lead to breakthroughs in the treatment 
of various genetic disorders. Inherited mutations 
in specific genes can predispose the individual 
to diseases. The risk of developing cancer can be 
markedly increased if there is a gene-diet interaction. 
Twin studies showed that the probability of identical 
twins developing the same cancer is less than 10%, 
indicating that the environment is an important 
factor in cancer susceptibility. For example, 
studies have shown that familial susceptibility 
is only responsible for relatively rare cancer 
variants.13 In addition, most twin studies make the 
assumption that both twins are exposed to the same 
environment and the absence of any environment-
genotype interaction.13 Differences in epigenetic 
modifications between twins can also explain the 
differences in susceptibility between twins.14 
As nutrition is a major component of the 
environmental conditions which can putatively 
interact with the genotype to bring about a 
phenotypical change, any disease or condition 
that is associated with genetic and/or nutritional 
components can be targeted for nutrigenomic 
studies in order to test whether dietary intervention 
can affect the outcome. Differences in genetic 
makeup (genotype), as well as nutrient deficiencies, 
are factors in various diseases, including cancer, 
cardiovascular, digestive and inflammatory diseases. 
Nutrigenomics is addressing why some people can 
control disease with diet, whereas others require 
drugs. Therefore, nutrigenomics is expected to 
significantly contribute to personalised medicine.
The expected benefits from nutrigenomics 
are tremendous and encompass: (1) a better 
understanding of the toxicity and safety profile of 
macro- and micronutrients; (2) the prevention of 
certain diet-associated diseases; (3) the enjoyment 
of otherwise less healthy food by individuals whose 
health is not likely to be affected; (4) the avoidance 
of unhelpful dietary supplements that are routinely 
used by certain people, and (5) the prevention of 
diseases and an increase in life expectancy.
Despite its recognised future potential benefits, 
nutrigenomics nevertheless raises a number of 
ethical issues and risks that are similar to ‘genethics’ 
or ethics in genetics: (1) a predisposition to develop 
a disease might trigger anxiety and stress in the 
individual; (2) the privacy of the patient might be 
jeopardised (for instance in deciding who should 
know the results); (3) potential discrimination 
against affected individuals by employers, health 
insurance companies, family, etc.; (4) the crucial 
need for well-qualified physicians to interpret 
nutrigenomic reports and make the appropriate 
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decisions, and (5) other unrecognised risks.
Despite its early positive impact and the very 
few diet-gene interactions that have been well 
characterised to yield useful information (e.g. 
obesity), far more research is needed before 
nutrigenomic expectations become a reality. 
Understanding the mechanisms by which some 
components in food interact with certain genes 
that can predispose to metabolic diseases would 
help people to avoid certain types of food; this 
can subsequently lead to the prevention of certain 
diseases. Furthermore, knowing the right amount 
and the type of specific nutrients that our body 
requires would positively impact the management 
of our health. Although studies conducted in this 
field have been costly and difficult, the results 
are deemed to be helpful for the advancement of 
medical technologies pertaining to health care 
(personalised medicine) and weight management. 
Ongoing nutrigenomic studies in our laboratory 
aim to establish the relationship between various 
combinations of powerful specific natural 
compounds that can target specific diseases (e.g. 
a combination of phytochemicals specific to 
treat cancer). More interestingly, in addition to 
understanding the basic molecular mechanisms 
of action of certain compounds in cancer, 
functional nutrigenomics will ultimately lead to 
the identification and validation of candidate gene 
targets that can pave the way towards the design of 
anti-cancer therapeutic strategies. 
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